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Abstract Hepatic encephalopathy is a common complica-
tion of cirrhosis. The degree of neuro-psychiatric impair-
ment is highly variable and its clinical staging subjective.
We investigated whether eye movement response times—
saccadic latencies—could serve as an indicator of enceph-
alopathy. We studied the association between saccadic
latency, liver function and paper- and pencil tests in 70
patients with cirrhosis and 31 patients after liver transplan-
tation. The tests included the porto-systemic encephalopa-
thy (PSE-) test, critical flicker frequency, MELD score and
ammonia concentration. A normal range for saccades was
established in 31 control subjects. Clinical and biochemical
parameters of liver, blood, and kidney function were also
determined. Median saccadic latencies were significantly
longer in patients with liver cirrhosis when compared to
patients after liver transplantation (244 ms vs. 278 ms p<
0.001). Both patient groups had prolonged saccadic latency
when compared to an age matched control group (175 ms).
The reciprocal of median saccadic latency (μ) correlated
with PSE tests, MELD score and critical flicker frequency.
A significant correlation between the saccadic latency
parameter early slope (σE) that represents the prevalence
of early saccades and partial pressure of ammonia was also
noted. Psychometric test performance, but not saccadic
latency, correlated with blood urea and sodium concen-
trations. Saccadic latency represents an objective and
quantitative parameter of hepatic encephalopathy. Unlike
psychometric test performance, these ocular responses were
unaffected by renal function and can be obtained clinically
within a matter of minutes by non-trained personnel.
Keywords Liver cirrhosis.Liver transplantation.
Eye movements.Brain function.Ammonia
Introduction
Hepatic encephalopathy (HE) is a common complication of
liver cirrhosis. The diagnosis is made in the presence of
acute or chronic liver disease, with or without porto-
systemic shunting, after other causes of encephalopathy,
such as intracranial haemorrhage, stroke, intoxication,
severe electrolyte imbalances, acid–base disorders, acute
infection and hypoxia have been excluded (Ferenci et al.
2002). Although encephalopathy is associated with EEG
abnormalities and changes on magnetic resonance imaging,
none of these is specific or can be readily used for follow
up to assess disease progression (Rovira et al. 2002).
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DOI 10.1007/s11011-010-9210-1Clinical presentation is highly variable and ranges from
minimal impairment of cognitive function to coma. Thirty
per cent of patients with liver cirrhosis have obvious
psychomotor impairment but sub-clinical changes in
cognitive function are presenti nm o s tp a t i e n t s( J a l a na n d
Hayes 1997). This variability makes grading individual
patients and assessing their response to treatment more
difficult. Despite the advantages of clinical grading using
the West-Haven criteria, this method is subjective and
therefore of limited use both clinically and for research
(Mechtcheriakov et al. 2005).
Accurate grading of HE remains challenging. The
plasma concentration of ammonia correlates poorly with
degree of HE (Kramer et al. 2000) even if it is determined
in arterial blood and its partial pressure calculated from
the pH (Kramer et al. 2000; Manning 1964). Ammonia is
believed to be central to the pathogenesis of HE associated
with acute liver failure (Butterworth 2002; Butterworth et
al. 1987; Kramer 2004).
Psychometric tests are an alterbnative method for
assessing and grading HE (Kircheis et al. 2002). The
porto-systemic encephalopathy (PSE) test comprises of a
test panel, in which pattern recognition, memory, attention
span and motor impairment are assessed. Although this is
objective and reproducible, its application in clinical
practice is limited by the time requirements and need for
a trained assessor (Kircheis et al. 2007).
Another sensitive and quantitative tool for grading
encephalopathy is critical flicker frequency (CFF), deter-
mined using the Hepatonorm Analyzer™, an instrument
designed for bed-side use (Kircheis et al. 2002). CFF is
thought to be principally dependent on retinal function
which is believed to mirror the cerebral changes seen in HE
(Kircheis et al. 2002). The test has mainly proved useful for
quantifying mild to moderate impairment as it requires
patient compliance.
Somooth pursuit eye movements have been more
recently shown to correlate with the degree of neurologic
impariment, but their use is limited by the need for
specialized equipment and head fixation (Montagnese et
al. 2005).
To evaluate the feasibilty of saccadometry for the
diagnosis and grading of HE, saccadic latencies which
typically range between 150 ms and 220 ms in normal
subjects (Reddi and Carpenter 2000) were assessed in
patients with liver cirrhosis and after liver transplantation.
Saccadic latencies represent the time taken for patients to
respond to a visual target by generating an eye movement
to fixate on it. This requires cortical processing and
prolonged saccadic latencies have been found in cerebral
impairment in schizophrenia (Karoumi et al. 1998) and
neurodegenerative diseases (Parkinson’s and Huntingdon’s
disease)(Ali et al. 2006; Foltynie et al. 2004; Michell et al.
2006) as well as lysosomal storage diseases (Roos et al.
2006).
Latencies are highly variable and this randomness has
tended to limit their use for staging and diagnosis of
neurological diseases (Ali et al. 2006; Antoniades et al.
2007; Carpenter et al. 2002; Khan et al. 1999; Michell et al.
2006; Nouraei et al. 2003; Pearson et al. 2007). However
despite their randomness, saccadic latencies follow a
characteristic skewed distribution that can be transformed
to a Gaussian distribution by plotting their cumulative
frequency against the reciprocal of latency (Figs. 1 and 2).
Consequently, if this frequency is plotted on a probit scale,
the majority of saccadic latencies lie on a straight line
(Fig. 3) (Carpenter and Williams 1995). In this manner, a
complex dataset of usually 200–500 individual saccadic
latencies from a single patient can be described by just three
parameters. These parameters are (μ), the mean of the
reciprocal of saccadic latency, (σ), its standard deviation,
and (σE), the standard deviation of the sub-popuation of
early saccades, that escape normal tonic inhibition from the
cortex (typically <5% of saccades). This forms the basis of
the LATER model (linear approach to threshold with
ergodic rate) of decision making which essentially
describes how pre-test likelihood and urgency affect
decision time and threshold in neuronal circuits (Reddi
and Carpenter 2000). (see www.cudos.ac.uk/later.html for
further details).
The severity of HE typically correlates with degree of
liver function impairment and transplantation is associated
with major improvement of encephalopathy in a majority of
patients (Moore et al. 2000), although residual neuro-
psychiatric impairment has been reported long-term post-
operatively (Mechtcheriakov et al. 2004). We sought to
determine the value of saccadometry for diagnosis and
grading of HE and studied saccadic latencies in patients
with liver cirrhosis before and after transplantation as well
as in controls and found that saccadic latencies were
significantly shorter in controls than in transplanted patients
and in patients with liver cirrhosis, where differences
between transplanted and cirrhotic patients were also highly
significant. Results were correlated with those from
established tests for liver and brain function as well as
inflammatory, metabolic and renal blood tests. This
correlation analysis showed the practical value of saccad-
ometry which correlates well with the psychometric test
score and MELD score.
Patients and methods
This study was approved by the Research Ethics Committee
of Innsbruck Medical University (UN3231) where this
study was conducted. Informed consent was obtained from
286 Metab Brain Dis (2010) 25:285–295all patients before study enrolment. Seventy cirrhotic
patients were recruited to the study, nine of whom
underwent liver transplantation during the study period
and could be reassessed afterwards. We also recruited an
additional 22 patients who had previously undergone liver
transplantation, enabling us to study 31 transplanted
patients. As a control, saccadic latencies were also
determined in 31 healthy volunteers matched for age and
sex. Demographic data, cause of liver disease, renal and
liver function are presented in Table 1. No statistically
significant differences for age or gender were noted
between the pre- and post-transplant patient groups.
Amongst the cirrhotic patients, fatty liver disease was the
most common cause of cirrhosis (59.7%) and also the most
common indication for liver transplantation (30.3%).
UNOS modified MELD scores were calculated on the
basis of the INR, bilirubin and creatinine concentrations but
excluding the extra score-points for hepatocellular carcino-
ma. All investigations took place between 9 and 12 am. As
benzodiazepines influence saccadic latency (de Visser et al.
2003), patients who had received these drugs within 72 h
prior to assessment were excluded. Other clinical biochem-
ical parameters were determined on the same day using
routine methods including urea, creatinine, sodium, potas-
Fig. 2 Paired measurements of median saccadic latency before and after
transplant in nine patients: the line represents the expected relationship if
there is no change. Five patients showed significant reduction in latency,
threepatientsshowedasignificantincrease.(Changesinmediansaccadic
latency were tested for significance in each patient by student’s t-test of
log transformed data. Two hundred individual saccadic latency times
were recorded for each patient before and 200 after transplantation).
Note that a decrease in latency tends to occur in patients whose
latencies were longer before the operation, i.e. those whose saccades
were more severely affected by cirrhosis
Fig. 1 Box-Whisker blots for
individual surrogate markers of
hepatic encephalopathy. The me-
dian is indicated by a horizontal
line. Boxes indicate the 25th and
75th percentile and whiskers the
range. Outliers are marked by
circles. For saccadic latency the
median of 200 individual saccad-
ic latency times in each patient
was calculated and for critical
flicker frequency the median of 6
individual measurements in each
patient was calculated. (Note that
thedifferencesinnumbersaredue
to difficulties in obtaining PSE
test results, CFF and pNH3 in
some patiens)
Metab Brain Dis (2010) 25:285–295 287sium, chloride, transaminases (ALT, AST and γ-GT), blood
count, haemoglobin concentration, prothrombin time,
C-reactive protein, albumin and bilirubin. Partial pressure
of ammonia was calculated in 69 patients using arterial
blood (Kramer et al. 2000), according to the method of
Manning (Manning 1964).
Psychometric test
Patients underwent standard investigations for HE. Paper-
Pencil Tests were carried out with all patients, including the
number connection tests A and B, the digit-symbol test, the
serial dotting test and line tracing (Ferenci et al. 2002;
Table 1 Characteristics of patients enrolled in this study
Patients with liver cirrhosis (n=70) Patients after liver transplantation (n=31
a)
Sex male 45 (64.3%) 24 (75%)
female 25 (35.7%) 8 (25%)
Age mean (± SD) 54.4 (±11.4) 56.8 (±10.4)
Disease fatty liver disease 43 (59.7%) 9 (28.1%)
hepatitis C cirrhosis 12 (17.1%) 6 (18.8%)
others 15 (21.4%) 17 (53.1%)
UNOS modified MELD score: mean (95% CI) 15.1 (14.1–17.5) n/a
Creatinine mean (95% CI) 1.1 (0.9–1.3) 1.1 (1.0–1.2)
Bilirubin mean (95% CI) 5.8 (3.2–8.5) 2.4 (0.7–4.2)
INR mean (95% CI) 1.5 (1.3–1.7) 1.1 (1.0–1.1)
aNine patients who were analyzed before and after liver transplantation were counted twice in both groups. Other causes of cirrhosis included autoimmune
hepatitis, hepatitis B, cholestatic and metabolic liver diseases
Fig. 3 Scatter blots of surrogate
markers of hepatic encephalop-
athy. Results from correlation
tests are shown in Table 4. In-
dividual results are depicted by
circles. Regression lines and
95% confidence intervals for
linear regression are shown
288 Metab Brain Dis (2010) 25:285–295Schomerus and Hamster 1998; Schomerus et al. 1999;
Weissenborn et al. 2001). We applied the PSE syndrome test
of Swets Test Services (Frankfurt, Germany) which was
standardized for age in healthy German volunteers. Normal
results range from −4 to +6 points. A score of −5 points or
less is considered pathologic. Four different forms of the test
are available for follow-up investigations.
Critical flicker frequency
CFFwas determined using the HepatoNorm
TM Analyzer
(Kolassa Merz Vienna, Austria) consisting of a head
mounted projection unit and a hand held micro-controller.
For this test, the patient is instructed to concentrate on a red
spot which flickers with a frequency of 60 Hz. The
frequency is then decreased with a variable rate of 0.1 to
1.0 Hz per second to a final frequency of 25 Hz. Healthy
volunteers are able to recognize flickering at ~42 Hz
(Kircheis et al. 2002), whereas patients with hepatic
encephalopathy have a reduced ‘critical flicker frequency’
with a threshold of 38–39 Hz (Romero-Gomez et al. 2007).
After a training measurement, six single measurements were
carried out and the median of the 6 readings was calculated.
Saccadic latencies
Saccadic latency was measured using a 1 kHz, head-mounted,
non-invasive infra-red scleral reflection oculometer (Ober
consulting, Poland) (Ober et al. 2003), whose output was
low-pass filtered at 250 Hz with 12-bit resolution. A
differential amplifier eliminated any convergence and ver-
gence movements. Three laser diodes projecting red visual
targets with an intensity of 13 cdm
−2 were mounted on top of
the device, ensuring that they were presented in a fixed
position (one in the midline, the others at 10° to right and left)
relative to the head. This obviates the need for head
immobilization which has been a necessary feature of most
other oculometers (Cairney et al. 2005). Patients were
instructed to ‘look at the red dot’, and performed a standard
saccadic step task in which a central target was presented for a
random fore-period in the range 0.5-1 s, and after its
extinction a second target was presented randomly either to
the left or the right and remained illuminated until 25 ms after
the end of the saccade or for 1 s, whichever was shorter. The
target would thus appear to jump randomly 10° horizontally
to the right or left. This was repeated to generate 200 trials,
typically taking about 5–8 min with 50% occurring to the
right and 50% to the left on average; data were stored in the
portable saccadometer and then downloaded onto a personal
computer running Latency Meter 2.3 (Nouraei et al. 2003)
which automatically purged erroneous data such as artefacts
caused by blinks, head movements and saccades in the wrong
direction. Saccadic latencies less than 50 ms were also
ignored as these would be too fast to have been evoked by
the visual stimuli.
Saccadic latency distributions were analyzed using the
application SPIC (Carpenter 1994) which calculates best-fit
LATER parameters (μ, σ and σE) by minimization of
the Kolmogorov-Smirnov one sample (KS-1) statistic
(Kolmogorov 1941) using 10 ms bins. These parameters are
(μ), the mean of the reciprocal of saccadic latency, (σ), its
standard deviation, and (σE), the standard deviation of the
sub-popuation of early saccades, if any. For statistical
comparisons μ, the reciprocal value of the saccadic latency
(its units are sec
−1 or Hertz) is preferred for statistical analysis
over the median saccadic latency because of its normal
distribution.
LATER is discussed in detail elsewhere (Carpenter and
Williams 1995; Reddi et al. 2003; Temel et al. 2009) (see
Supplementary Figure).
Statistical analysis
Study data of patients enrolled in this study were analyzed in
SPSS version 15.0. Patients were divided into controls (n=31)
a group of cirrhotic patients (n=70) and a group of patients
who had undergone liver transplantation (n=31). Normality
of distribution was tested by Kolmogorov-Smirnov curve
fitting analysis. If the distribution was normal, ANOVA or
t-test for independent samples was carried out between the
two groups. For the non-normally distributed data, the
Mann–Whitney-U test was used. Paired analysis of the data
from the nine patients who were examined both before and
after liver transplantation, was performed using the paired
t-test and, for non-Gaussian data, the Wilcoxon test. Corre-
lation analysis was carried out using the Pearson or Spearman
rank test as appropriate.
Results
Hepatic encephalopathy before and after liver transplantation
Saccadic latency, psychometric test performance and CFF were
assessed in patients with cirrhosis and in patients who had
undergone liver transplantation. In addition, arterial partial
pressure of ammonia was calculated for as many of these
patients as technically possible. Table 2 shows statistically
significant differences between these groups with better
psychometric test performance (−2v s−8 p<0.001), a shorter
median saccadic latency in the transplanted group, i.e. a
higher μ (4.1 vs 3.6 Hz p=0.028) and a lower partial pressure
of ammonia (2.6 vs 5.9×10
−5 mmHg p<0.001). The age and
sex-matched control group had significantly shorter mean
saccadic latency when compared with cirrhosis patients and
patients after liver transplantation (Table 2,F i g .1). Cluster
Metab Brain Dis (2010) 25:285–295 289analysis of all combined saccadic latency parameters (calcu-
lated from the LATER model) showed significant differences
between the three groups (Table 2). The mean CFF was
higher in patients after liver transplantation, but did not reach
statistical significance.
Nine individual patients were assessed before and after
transplantation at our centre. Paired analysis for the
individuals showed improved psychometric test perfor-
mance by a mean of 5 points (p=0.014). Arterial partial
pressure of ammonia (pNH3) decreased by a mean of 3.96×
10
−5 mmHg after liver transplantation (p=0.014) in this
paired analysis. The mean reduction in saccadic latency
after liver transplantion was 7.7 ms, which did not reach
statistical significane in this smaller subgroup of 9 patients
(Table 3). However as individuals there was a significant
improvement in 5 patients and no change in one patient. In
the three patients who showed a prolongation of saccadic
latencies after liver transplantation, these changes mirrored
clinical derterioration. Paired measurements of median
saccadic latency before and after transplant showed that a
decrease in latency tends to occur in patients whose
latencies were longer before the operation, i.e. those whose
saccades were more severely affected by cirrhosis (Fig. 2).
Figure 4 and Table 4 show the data from a representative
patient who was tested repeatedly whilst awaiting a donor
liver. Clinically his encephalopathy worsened significantly
whilst on the waiting list and improved markedly post-
transplant—a result that is accurately mirrored by the
changes in his median latencies and is highly statistically
significant. We also analyzed the distribution of data from
those of our patients who did not show improvement in
their median reaction times post-transplant.
Correlation analysis of surrogate parameters for hepatic
encephalopathy
Interdependence between surrogate parameters for grading
of hepatic encephalopathy were assessed by correlation
analysis. The significant relationship between median
latency (μ), PSE Test score, CFF and MELD score is
shown in Fig. 3. The LATER parameter σE correlated
negatively with the partial pressure of ammonia. Table 5
shows the positive correlation between MELD score and
pNH3 as well as a negative correlation between PSE test
score and MELD score which also reached statistical
significance. No significant correlation between critical
flicker frequency, PSE test score, MELD score and pNH3
were found.
Specificity of surrogate markers for hepatic encephalopathy
The effect of co-morbidities on surrogate markers was
assessed by their correlation with biochemical parameters of
liver function.
Table 2 Surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants. Medians,
95% confidence intervals and sample size [n] are shown. Differences between groups were tested for statistical significance by Student’s t-test or
Mann–Whitney-U-Test for independent samples
Patients with liver
cirrhosis median
(95% CI) [n]
Patients after liver
transplantation median
(95% CI) [n]
Control
subjects [n]
Significance
pNH3×10
−5 mmHg 5.9 (5.3–6.9) [48] 2.6 (2.2–3.2) [21] n.a. <0.001
PSE test −8.0 (−9.1– −6.6) [59] −2.0 (−4.1– −1.2) [31] n.a. <0.001
median CFF [Hz] 38.8 (37.9–40.6) [68] 40.1 (38.9–42.7) [31] n.a. 0.132
Median saccadic
latency [ms]
278 (256–303) [70] 244 (222–263) [31] 175 (175–196) [31] 0.028
a
<0.001
b
<0.001
c
LATER parameters μ 3.6 (3.3–3.9) [70] 4.1 (3.8–4.5) [31] 5.7 (5.1–5.8) [31] 0.028
a
<0.001
b
<0.001
c
σ 1.0 (0.9–1.0) [70] 1.1 (0.9–1.2) [31] 0.9 (0.84–1.1) [31] 0.195
a
0.738
b
0.298
b
σ E 2.77 (1.82–2.98) [70] 3.64 (2.22–3.88) [31] 2.20 (0.97–3.1) [31] 0.287
a
0.292
b
0.307
c
ANOVA of all LATER parameters
(combined sum of squares)
liver cirrhosis vs. after LT
p=0.018
after LT vs. controls
p=0.005
controls vs. liver cirrhosis
p<0.001
Differences in LATER parameters between the three groups were analyzed by ANOVA (separate sum of squares;
apatients with liver cirrhosis vs.
patients after liver transplantation,
bpatients with liver cirrhosis vs. controls,
cpatients after liver transplantation vs. controls)
Table 2 Surrogate markers for hepatic encephalopathy in patients
with liver cirrhosis and those who have received liver transplants.
Medians, 95% confidence intervals and sample size [n] are shown.
Differences between groups were tested for statistical significance by
Student’s t-test or Mann–Whitney-U-Test for independent samples
290 Metab Brain Dis (2010) 25:285–295Saccadic latencies are known to increase with age
(Irving et al. 2006), and this was confirmed by a positive
correlation with age (r=0.457, p<0.001). In addition to the
correlation with the other parameters of encephalopathy
(PSE Test, critical flicker frequency), a significant correla-
tion was also found between μ (median saccadic latency)
and the platelet count (r=0.319 p=0.001). σE correlated
negatively with bilirubin (r=−0.212 p=0.032) and nega-
tively with INR (r=−0.22 p=0.02).
The negative effect of impaired renal function and
hyponatraemia/hypokalaemia on neuropsychiatric perfor-
mance is illustrated by a negative correlation between the
PSE Test score and urea (r=−0.29 p=0.005) and a positive
correlation with sodium and potassium (r=0.361 p=0.005,
r=0.213 p=0.05). PSE test score also correlated with
haemoglobin, platelets INR and albumin. Renal function
and electrolyte imbalances appear to have only a minor
effect on saccadic latency and critical flicker frequency.
Finally, pNH3 correlated significantly with age, leucocyte
count, haemoglobin, platelets and AST.
Aetiology of liver disease and hepatic encephalopathy
To test if patients with alcoholic liver disease presented
with more severe impairment all cirrhotic patients were
grouped according to the underlying cause of their liver
disease. Psychometric test performance, median saccadic
latency (μ), CFF and MELD score were slightly worse in
the alcoholic liver disease group, when compared with
patients with other causes of liver cirrhosis, but these
differences did not reach statistical significance (p>0.05).
Discussion
Hepatic encephalopathy is a common complication of
chronic liver disease and affects prognosis (Bustamante et
al. 1999) and quality of life (Groeneweg et al. 1998; Tarter
et al. 1991; Wein et al. 2004). Clinical grading of its
severity, usually by the West Haven criteria, is subjective
and has led to its exclusion from organ allocation criteria.
There is therefore an urgent need for quantitative and
objective bed-side tools for the assessment of neuro-
psychiatric impairment in patients with cirrhosis.
We found that cirrhotic patients have prolonged saccadic
latencies when compared with transplanted patients. Analysis
alsoshowedthatlatenciescorrelatepositivelywiththe MELD
score and negatively with psychometric testing results,
validating latency as an objective indicator of cognitive
impairment in liver disease. Median latencies correlated
negatively with critical flicker frequency, but in contrast to a
previousstudy,nocorrelationbetweenCCFandpsychometric
test performance was found (Kircheis et al. 2002). The CCF
was originally developed as a tool for the assessment of
Fig. 4 Reciprobit plots summarizing the saccadic data from the
patient presented in Table 1. The intercept of the 50
th percentile and
the best-fit line indicates median saccadic latency (projection to the
abscissa indicated by the dashed arrows). The slope of the line
corresponds to the LATER parameter σ. Note that improvement of
mean saccadic latency after transplantation is associated with a shift of
the regression line, implying an increase in the LATER parameter σE
Table 3 Paired analysis for surrogate parameters of hepatic encephalopathy in nine individual patients who were assessed before and after liver
transplantation. (pNH3 was only available for three patients). Differences between groups were tested for statistical significance by Student’s t-test
or the Wilcoxon test for paired samples
Patients with
liver cirrhosis median
(95% CI)
Patients after
liver transplantation
median (95% CI)
Mean difference
before and after
LT (95% CI)
Significance
pNH3×10
−5 mmHg 6.0 (3.3–8.1) 1.6 (1.3–2.1) −3.96 (−1.89– −6.4) 0.014
PSE test −10.0 (−15.9–3.4) −10.0 (−20.0–5.9) 5.00 (−8.2– −1.9) 0.006
Median CFF [Hz] 34.6 (12.4–55.5) 44.8 (4.8–77.4) 3.96 (−9.3– −1.33) 0.123
LATER parameters μ 2.8 (1.8–4.4) 4.0 (2.3–5.2) 0.13 (0.67– −0.41) 0.602
σ 1.1 (0.3–1.6) 1.0 (0.9–1.1) −0.04 (0.42– −0.50) 0.841
σ E 3.4 (−4.3–10.5) 4.1 (−3.1–8.6) 0.47 (2.5– −1.56) 0.607
Table 3 Paired analysis for surrogate parameters of hepatic enceph-
alopathy in nine individual patients who were assessed before and after
liver transplantation. (pNH3 was only available for three patients).
Differences between groups were tested for statistical significance by
Student’s t-test or the Wilcoxon test for paired samples
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encephalopathy during follow up of a single representative patient
who initially presented with cholestatic decompensation of alcoholic
liver cirrhosis three years after initial diagnosis. At the time of
presentation, portal hypertension with hepato-splenomegaly and
oesophageal varices, as well as grade II hepatic encephalopathy were
diagnosed. During follow up after three months hepatic encephalop-
athy had deteriorated despite apparent improvement in cholestasis. In
the 5 month, this patient received a liver transplant and was then re-
assessed for hepatic encephalopathy at day 26 after surgery
Month 1 presentation with
decompensated cirrhosis
Month 3 decompensation of hepatic
encephalopathy
Month 6 26 days after liver
transplantation
Creatinine
(0.67–1.17 mg/dl)
0.64 mg/dl 0.9 mg/dl 1.1 mg/dl
Prothrombin time
(70–130%)
49% 36% 90%
C-reactive protein
(0–0.7 mg/dl)
2.49 mg/dl 3.55 mg/dl 1.1 mg/dl
Bilirubin
(0–1.28 mg/dl)
36.26 mg/dl 24.07 mg/dl 1.08 mg/dl
MELD score 18.05 21.09 8.07
Median critical flicker
frequency
33.9 Hz 45.75 Hz 41.65 Hz
Psychometric test
performance
−9 −17 −4
Median saccadic latency 352.5 ms 462.5 ms 271 ms
Table 5 Correlations between surrogate markers of hepatic encephalopathy
pNH3 MELD score Critical
flicker
frequency
PSE Test performance LATER parameters
μσσ E
a
pNH3 R 0.335 −0.169 −0.336 −0.224 −0.047 −0.279
Sig. 0.005 0.175 0.008 0.064 0.704 0.020
N 69 66 62 69 69 69
MELD score R 0.335 −0.037 −0.485 −0.272 0.017 −0.165
Sig. 0.005 0.721 <0.001 0.006 0.869 0.100
N 69 98 90 101 101 101
Critical flicker frequency R −0.169 −0.037 0.107 0.318 0.046 0.117
Sig. 0.175 0.721 0.319 0.001 0.653 0.250
N6 6 9 8 8 9 99 99 99
PSE Test performance R −0.336 −0.485 0.107 0.495 −0.025 0.058
Sig. 0.008 <0.001 0.319 <0.001 0.810 0.583
N 62 90 89 92 92 92
LATER parameters μ R −0.224 −0.272 0.318 0.495 0.051 −0.104
Sig. 0.064 0.006 0.001 <0.001 0.556 0.234
N6 9 101 99 92 133 133
σ R −0.047 0.017 0.046 −0.025 0.051 0.168
Sig. 0.704 0.869 0.653 0.810 0.556 0.054
N 69 101 99 92 133 133
σE
a R −0.279 −0.16 0.117 0.058 −0.104 0.168
Sig. 0.020 0.10 0.250 0.583 0.234 0.054
N 69 101 99 92 133 133
aCorrelation of σE and other surrogate parameters was tested by Spearman rank correlation analysis. For all other parameters, Pearson correlation analysis
was carried out, since were the normally distributed (Kolmogorov-Smirnov test). Statistically significant correlations (p<0.05) are highlighted in bold
292 Metab Brain Dis (2010) 25:285–295minimal or mild hepatic encephalopathy. Our study included
patients with more advanced neuro-psychiatric impairment
and differences in the study population may explain this
discrepancy. Unlike CCF assessment, measuring saccadic
latencies requires little patient comprehension or compliance
as these movements are triggered sub-consciously. They can
therefore be assessed even in those patients who have severe
cognitive impairment (Roos et al. 2008); saccadometry may
be particularly helpful at the more severe end of the clinical
spectrum.
In this study, we normally made 200 single measure-
ments to calculate median saccadic latency, taking around
10 min to collect: approximately the same time required to
obtain 8 single critical flicker frequencies (Kircheis et al.
2002). We also found that the distribution of repeated CCF
measurements in the same patient is not Gaussian. To
minimize the effects of potential outliers, the median of
repeated measurements was calculated for each patient.
With increasing severity of hepatic encephalopathy, the
task of recognizing the flickering light in the CCF test
becomes more difficult and the results increasingly
inconsistent.
The negative correlation between psychometric test
performance and urea and the positive correlation with
sodium and potassium suggest a direct effect of impaired
renal function or hyponatraemia on brain function. No such
association was seen between mild to moderate electrolyte
imbalances or mildly impaired renal function and saccadic
latency or critical flicker frequency, suggesting their
specificity for HE.
Recentstudieshaveshownthatinflammationisakeyfactor
in the pathogenesis of hepatic encephalopathy (Shawcross et
al.2004). However, no correlation between C-reactive protein
and any surrogate parameters of hepatic encephalopathy
including saccadic latency parameters (LATER parameters)
was found. Because patients with infectious complications or
severe inflammation were excluded from the study, a
different design would be required to test if saccadic latencies
are a sensitive parameter for spetic encephalopathy and to
assess the interaction between inflammation and ammonia in
the pathogenesis of hepatic encephalopathy.
Whereas saccadic latencies increase with age (Irving et al.
2006) our study showed no relationship between age and
CCF, suggesting that saccadic latency is more sensitive for
subtle cognitive impairment, as in aging. To determine if
latency is an independent prognostic parameter in cirrhosis—
as suggested by its correlation with the MELD score—will
require further prospective studies. Although hepatic enceph-
alopathy is a common complication of cirrhosis, it is not
known if the prognostic value is due to the fact that hepatic
encephalopathy itself is also a surrogate marker of liver
function (Bustamante et al. 1999). Quantitative assessment of
neurological impairment in patients with cirrhosis CFF or
saccadic latency recordings offers a way to study the impact
of encephalopathy on patient outcome.
Rather than simply relying on correlations between latency
and other markers of liver function we recorded individual
improvement in latencies after patients were transplanted. As
expected, we found improvements in their individual median
saccadic latencies after surgery, but this difference did not
reach statistical significance (p>0.05). Psychometric test
performance improved significantly after liver transplantation,
validating our patient cohort as a model system for hepatic
encephalopathy. In two patients, median saccadic latencies
increased after liver transplantation and this may reflect
irreversible and progressive neurological deterioration
(Mechtcheriakov et al. 2004) or result from immunosup-
pressive therapy (Lewis and Howdle 2003; Walker and
Brochstein 1988; Wijdicks 2001). This notion is supported
by the significant difference seen between the transplanted
patient group and the age and sex-matched healthy control
subjects.
We also noted a positive correlation between the
prevalence of early saccades and pNH3, which suggests a
selective neurotoxic effect of ammonia within the brain,
since early saccades are believed to represent saccades
initiated sub-cortically that escape normal tonic inhibition
from the cortex, whereas the majority of saccades are
controlled by neural ‘decision units’ in the cortex (Schiller
and Tehovnik 2001). Assessment of saccadic latencies and
evaluation of the data with the LATER model therefore
offers a practical tool to study higher cerebral neurophys-
iology in liver cirrhosis.
In conclusion, our study suggests that median saccadic
latency is an objective and specific marker of hepatic
encephalopathy and can be reliably determined in patients
even at advanced stages of neurological impairment. Saccadic
latencies are unaffected by kidney function, plasma sodium
concentration or inflammatory markers, making them an
excellent tool with which to assess hepatic encephalopathy in
clinical practice.
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